51 results on '"Robesti, D"'
Search Results
2. PSA doubling time thresholds in predicting clinical recurrence after biochemical recurrence in surgically treated prostate cancer patients. The Impact of nodal status and adjuvant radiotherapy
3. Does the accuracy of PSA density change according to prostate volume? Assessing the diagnostic accuracy at the extreme values of prostate volume in a large single institution series
4. Age-dependent effect of early salvage radiotherapy for biochemical recurrence in prostate cancer patients treated with radical prostatectomy
5. The significant added value of concomitant systematic prostate biopsies in addition to targeted sampling in patients with previous negative biopsies. Implications for accurate staging predictions from a large multi-institutional series
6. PSMA radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection: Updated results of a planned interim analysis of a prospective phase 2 study
7. Cancer control rates in adequate versus inadequate treatment with adjuvant immunotherapy instillations with BCG
8. External validation of the available nomograms for the identification of candidates for a staging extended pelvic lymph node dissection at the time of radical prostatectomy in prostate cancer patients preoperatively staged with PSMA PET
9. Identifying the optimal definition of PSA response after metastasis directed therapy in men with oligo-recurrent prostate cancer detected at PSMA PET
10. Long-term oncological outcomes of surgically managed very high-risk prostate cancer patients according to the STAMPEDE trial definition: Implications for the selection of candidates for clinical trials
11. Validation of the EAU risk groups for radical prostatectomy prostate cancer patients who experienced biochemical recurrence restaged with PSMA PET imaging and development of a novel tool
12. Incidence, risk factors and persistence of acute kidney injury following ureteroscopy and laser lithotripsy: Results from a tertiary care referral center
13. Four dimension analysis of heat generation during Ho:YAG and thulium fiber laser activation: An in vitro thermographic study
14. A novel PRECISE implemented predictive model to assess the risk of long-term disease reclassification in men on active surveillance. Results from a large, single institution series
15. The role of artificial intelligence for the detection of clinically significant prostate cancer at multiparametric magnetic resonance imaging
16. Optimizing the number of systematic cores during MRI target biopsy. Preliminary results from the prospective, paired-cohort SCOT Trial
17. Effect of Metastasis Directed Therapy (MDT) in men with PSMA PET detected recurrent prostate cancer according to time from primary treatment. Do men with late recurrences really benefit from MDT? Results from a large, single institution series
18. The importance of high volume providers in the diagnostic pathways of prostate cancer. Results from large, singe Institution series
19. Towards a tailored use of PSA density to decide when to avoid prostate biopsy in men with PIRADS 3 lesions according to the location of the index lesion at mp-MRI. Results of a large, multi-institutional series
20. How can we reduce the rates of false positive findings at mpMRI? The pivotal role of urologist expertise assessed in a large, single center series
21. A0057 - The significant added value of concomitant systematic prostate biopsies in addition to targeted sampling in patients with previous negative biopsies. Implications for accurate staging predictions from a large multi-institutional series.
22. A1023 - The impact of centralized uropathology review in the management of bladder cancer patients at the time of transurethral resection of the bladder.
23. A0440 - Four dimension analysis of heat generation during Ho:YAG and thulium fiber laser activation: An in vitro thermographic study.
24. A0818 - A novel PRECISE implemented predictive model to assess the risk of long-term disease reclassification in men on active surveillance. Results from a large, single institution series.
25. A0716 - Does the accuracy of PSA density change according to prostate volume? Assessing the diagnostic accuracy at the extreme values of prostate volume in a large single institution series.
26. A0715 - The importance of high volume providers in the diagnostic pathways of prostate cancer. Results from large, singe Institution series.
27. A0649 - Effect of Metastasis Directed Therapy (MDT) in men with PSMA PET detected recurrent prostate cancer according to time from primary treatment. Do men with late recurrences really benefit from MDT? Results from a large, single institution series.
28. A0612 - PSA doubling time thresholds in predicting clinical recurrence after biochemical recurrence in surgically treated prostate cancer patients. The Impact of nodal status and adjuvant radiotherapy.
29. A0610 - Identifying the optimal definition of PSA response after metastasis directed therapy in men with oligo-recurrent prostate cancer detected at PSMA PET.
30. A0511 - Age-dependent effect of early salvage radiotherapy for biochemical recurrence in prostate cancer patients treated with radical prostatectomy.
31. A0430 - External validation of the available nomograms for the identification of candidates for a staging extended pelvic lymph node dissection at the time of radical prostatectomy in prostate cancer patients preoperatively staged with PSMA PET.
32. A0365 - Cancer control rates in adequate versus inadequate treatment with adjuvant immunotherapy instillations with BCG.
33. P329 - How can we reduce the rates of false positive findings at mpMRI? The pivotal role of urologist expertise assessed in a large, single center series.
34. P311 - Towards a tailored use of PSA density to decide when to avoid prostate biopsy in men with PIRADS 3 lesions according to the location of the index lesion at mp-MRI. Results of a large, multi-institutional series.
35. P250 - Assessing the impact and timing of salvage radiation therapy in men with biochemically recurrent prostate cancer after radical prostatectomy and negative PSMA PET.
36. A0436 - PSMA radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection: Updated results of a planned interim analysis of a prospective phase 2 study
37. A0429 - Long-term oncological outcomes of surgically managed very high-risk prostate cancer patients according to the STAMPEDE trial definition: Implications for the selection of candidates for clinical trials.
38. A0055 - Optimizing the number of systematic cores during MRI target biopsy. Preliminary results from the prospective, paired-cohort SCOT Trial.
39. P354 - Incidence, risk factors and persistence of acute kidney injury following ureteroscopy and laser lithotripsy: Results from a tertiary care referral center.
40. P327 - Validation of the EAU risk groups for radical prostatectomy prostate cancer patients who experienced biochemical recurrence restaged with PSMA PET imaging and development of a novel tool.
41. P046 - The role of artificial intelligence for the detection of clinically significant prostate cancer at multiparametric magnetic resonance imaging.
42. Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [ 99m Tc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study.
43. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study.
44. Temperature profile during endourological laser activation: introducing the thermal safety distance concept.
45. Acknowledging acute kidney disease following ureteroscopy and laser lithotripsy: results from a tertiary care referral center.
46. Endourological society fellowship program: a real contribution to improve surgical outcomes of stone patients treated with ureteroscopy.
47. Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging.
48. The Impact of Second Opinion Expert Pathology Review in Patient Management at the Time of Transurethral Resection of the Bladder.
49. Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
50. Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.